Skip to main content

Biogen alums, MacArthur ‘genius’ launch new biotech with $50M

Nereid Therapeutics launched Monday with a $50 million investment from Apple Tree to expand on Princeton University professor Clifford Brangwynne’s research exploring cellular function and biomolecular condensates.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.